
<!-- saved from url=(0115)https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-begins-study-covid-19-antiviral-drug-2021-09-27/ -->
<html><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"></head><body onload="document._l();"><script id="boomr-if-as" src="./GUXHP-DSJ3S-GQA6N-F2B3E-4TCYW"></script></body></html>